These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand. Stehr-Green P; Radke S; Kieft C; Galloway Y; McNicholas A; Reid S Vaccine; 2008 Feb; 26(6):739-42. PubMed ID: 18187240 [TBL] [Abstract][Full Text] [Related]
5. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years. Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650 [TBL] [Abstract][Full Text] [Related]
6. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008. Shu M; Liu Q; Wang J; Ao R; Yang C; Fang G; Wan C; Guo W Vaccine; 2011 Apr; 29(18):3507-10. PubMed ID: 19909830 [TBL] [Abstract][Full Text] [Related]
7. Recurrent Henoch-Schönlein purpura in children. Prais D; Amir J; Nussinovitch M J Clin Rheumatol; 2007 Feb; 13(1):25-8. PubMed ID: 17278945 [TBL] [Abstract][Full Text] [Related]
8. MeNZB vaccine and epidemic control: when do you stop vaccinating? Loring BJ; Turner N; Petousis-Harris H Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134 [TBL] [Abstract][Full Text] [Related]
9. Phase II meningococcal B vesicle vaccine trial in New Zealand infants. Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. Kelly C; Arnold R; Galloway Y; O'Hallahan J Am J Epidemiol; 2007 Oct; 166(7):817-23. PubMed ID: 17615088 [TBL] [Abstract][Full Text] [Related]
11. Henoch-Schönlein purpura following meningitis C vaccination. Courtney PA; Patterson RN; Lee RJ Rheumatology (Oxford); 2001 Mar; 40(3):345-6. PubMed ID: 11285387 [No Abstract] [Full Text] [Related]
12. Meningococcal B immunisation in New Zealand: why haven't we seen the data? Bolland M N Z Med J; 2008 Mar; 121(1270):107-9. PubMed ID: 18364764 [No Abstract] [Full Text] [Related]
13. Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine. Wong SH; Lennon DR; Jackson CM; Stewart JM; Reid S; Ypma E; O'Hallahan JM; Oster P; Mulholland K; Martin DR Pediatr Infect Dis J; 2009 May; 28(5):385-90. PubMed ID: 19384263 [TBL] [Abstract][Full Text] [Related]
14. Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study. Da Dalt L; Zerbinati C; Strafella MS; Renna S; Riceputi L; Di Pietro P; Barabino P; Scanferla S; Raucci U; Mores N; Compagnone A; Da Cas R; Menniti-Ippolito F; Ital J Pediatr; 2016 Jun; 42(1):60. PubMed ID: 27316345 [TBL] [Abstract][Full Text] [Related]
15. Henoch-Schonlein purpura in children. Influence of age on the incidence of nephritis and arthritis. Hamdan JM; Barqawi MA Saudi Med J; 2008 Apr; 29(4):549-52. PubMed ID: 18382797 [TBL] [Abstract][Full Text] [Related]
16. A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Yang YH; Hung CF; Hsu CR; Wang LC; Chuang YH; Lin YT; Chiang BL Rheumatology (Oxford); 2005 May; 44(5):618-22. PubMed ID: 15671050 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of vaccine breakthrough cases following MeNZB vaccination. McNicholas A; Galloway Y; Martin D; Sexton K; O'Hallahan J N Z Med J; 2008 Apr; 121(1272):38-46. PubMed ID: 18425153 [TBL] [Abstract][Full Text] [Related]
18. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447 [TBL] [Abstract][Full Text] [Related]
19. Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome. Magnus P; Brubakk O; Nyland H; Wold BH; Gjessing HK; Brandt I; Eidem T; Nøkleby H; Stene-Larsen G Vaccine; 2009 Jan; 27(1):23-7. PubMed ID: 18984023 [TBL] [Abstract][Full Text] [Related]
20. The risk of bronchiolitis hospitalisation following administration of a group B meningococcal vaccine in New Zealand. Stehr-Green P; Galloway Y; Kieft C; McNicholas A N Z Med J; 2007 Oct; 120(1263):U2746. PubMed ID: 17972966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]